Innovative clinical trial design for pediatric therapeutics

Until approximately 15 years ago, sponsors rarely included children in the development of therapeutics. US and European legislation has resulted in an increase in the number of pediatric trials and specific label changes and dosing recommendations, although infants remain an understudied group. The...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Laughon, Matthew M, Benjamin, Daniel K, Capparelli, Edmund V, Kearns, Gregory L, Berezny, Katherine, Paul, Ian M, Wade, Kelly, Barrett, Jeff, Smith, Phillip Brian, Cohen-Wolkowiez, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2011
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3184526/
https://ncbi.nlm.nih.gov/pubmed/21980319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ecp.11.43
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller